Ida Robertsen
Universitetet i Oslo
H-index: 15
Europe-Norway
Top articles of Ida Robertsen
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight Individuals
Clinical Pharmacokinetics
2024/1
Intraindividual variability in absolute bioavailability and clearance of midazolam in healthy individuals
Clinical Pharmacokinetics
2023/7
Anders Åsberg
H-Index: 30
Ida Robertsen
H-Index: 8
Neither gastric bypass surgery nor diet-induced weight-loss affect OATP1B1 activity as measured by rosuvastatin oral clearance
Clinical Pharmacokinetics
2023/5
A Method for Evaluating Robustness of Limited Sampling Strategies—Exemplified by Serum Iohexol Clearance for Determination of Measured Glomerular Filtration Rate
Pharmaceutics
2023/4
Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients
Transplantation direct
2023/3/1
Ida Robertsen
H-Index: 8
Anders Åsberg
H-Index: 30
Response to:“Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time”
European Journal of Clinical Pharmacology
2022/11
Espen Molden
H-Index: 23
Ida Robertsen
H-Index: 8
Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity
Clinical and Translational Science
2022/11
Short‐and long‐term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity
British Journal of Clinical Pharmacology
2022/9
Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body …
European journal of clinical pharmacology
2022/8
Drug disposition protein quantification in matched human jejunum and liver from donors with obesity
Clinical Pharmacology & Therapeutics
2022/5
Short‐and long‐term effects of body weight loss following calorie restriction and gastric bypass on CYP3A‐activity–a non‐randomized three‐armed controlled trial
Clinical and Translational Science
2022/1
Proteomics‐informed prediction of rosuvastatin plasma profiles in patients with a wide range of body weight
Clinical Pharmacology & Therapeutics
2021/3
Correlation of body weight and composition with hepatic activities of cytochrome P450 enzymes
Journal of Pharmaceutical Sciences
2021/1/1
Ida Robertsen
H-Index: 8
Anders Åsberg
H-Index: 30
Increased systemic exposure of once‐daily tacrolimus in renal transplant recipients on marine omega‐3 fatty acid supplementation.
Transplant International
2021/7/1
Ida Robertsen
H-Index: 8
Anders Åsberg
H-Index: 30
Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
British Journal of Clinical Pharmacology
2020/12
Ida Robertsen
H-Index: 8
Anders Åsberg
H-Index: 30
Fasting Status and Circadian Variation Must be Considered When Performing AUC‐based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients
Clinical and translational science
2020/11
Ida Robertsen
H-Index: 8
Anders Åsberg
H-Index: 30
Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient—No Intervention Actually Needed
Transplantation Direct
2020/10/1
Anders Åsberg
H-Index: 30
Ida Robertsen
H-Index: 8
Measuring intracellular concentrations of calcineurin inhibitors: expert consensus from the international association of therapeutic drug monitoring and clinical toxicology …
Therapeutic drug monitoring
2020/10/1
Florian Lemaitre
H-Index: 16
Antonio D'Avolio
H-Index: 28
Ida Robertsen
H-Index: 8
Pierre Wallemacq
H-Index: 33
Chronic inhibition of CYP3A is temporarily reduced by each hemodialysis session in patients with end‐stage renal disease
Clinical Pharmacology & Therapeutics
2020/10
Anders Åsberg
H-Index: 30
Ida Robertsen
H-Index: 8
Tacrolimus area under the concentration versus time curve monitoring, using home-based volumetric absorptive capillary microsampling
Therapeutic Drug Monitoring
2020/6/1
Ida Robertsen
H-Index: 8
Anders Åsberg
H-Index: 30
